NO20061819L - Ligander - Google Patents
LiganderInfo
- Publication number
- NO20061819L NO20061819L NO20061819A NO20061819A NO20061819L NO 20061819 L NO20061819 L NO 20061819L NO 20061819 A NO20061819 A NO 20061819A NO 20061819 A NO20061819 A NO 20061819A NO 20061819 L NO20061819 L NO 20061819L
- Authority
- NO
- Norway
- Prior art keywords
- ligands
- olj
- diagnosis
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
En radioaktiv forbindelse med formel: der R1 og Ar er som definert i beskrivelsen, farmasøytisk akseptable salter derav, sammensetninger som inneholder slike forbindelser og anvendelser derav med diagnose av tilstander der OLJ nikotinreseptoren er involvert.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50573103P | 2003-09-25 | 2003-09-25 | |
PCT/GB2004/004116 WO2005030778A1 (en) | 2003-09-25 | 2004-09-24 | Ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20061819L true NO20061819L (no) | 2006-06-26 |
Family
ID=34393060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20061819A NO20061819L (no) | 2003-09-25 | 2006-04-25 | Ligander |
Country Status (14)
Country | Link |
---|---|
US (1) | US7982038B2 (no) |
EP (1) | EP1668016A1 (no) |
JP (1) | JP4792393B2 (no) |
KR (1) | KR20060102328A (no) |
CN (1) | CN1856497A (no) |
AU (2) | AU2004276061A1 (no) |
BR (1) | BRPI0414633A (no) |
CA (1) | CA2538705A1 (no) |
IL (1) | IL174218A0 (no) |
MX (1) | MXPA06003196A (no) |
NO (1) | NO20061819L (no) |
NZ (1) | NZ546414A (no) |
WO (1) | WO2005030778A1 (no) |
ZA (1) | ZA200602445B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200813067A (en) * | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5726189A (en) * | 1996-05-03 | 1998-03-10 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Method for imaging nicotinic acetylcholinergic receptors in the brain using radiolabeled pyridyl-7-azabicyclo 2.2.1!heptanes |
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
MXPA04010190A (es) * | 2002-04-18 | 2005-02-03 | Astrazeneca Ab | Compuestos heterociclicos. |
US7238715B2 (en) * | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
WO2004052889A1 (en) * | 2002-12-06 | 2004-06-24 | Pharmacia & Upjohn Company Llc | Compounds as radioligands for the diagnosis of disease |
US20050129610A1 (en) * | 2003-06-24 | 2005-06-16 | Johns Hopkins University | Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor |
-
2004
- 2004-09-24 CN CNA2004800277112A patent/CN1856497A/zh active Pending
- 2004-09-24 BR BRPI0414633-6A patent/BRPI0414633A/pt not_active IP Right Cessation
- 2004-09-24 NZ NZ546414A patent/NZ546414A/en unknown
- 2004-09-24 JP JP2006527486A patent/JP4792393B2/ja not_active Expired - Fee Related
- 2004-09-24 KR KR1020067005816A patent/KR20060102328A/ko not_active Application Discontinuation
- 2004-09-24 MX MXPA06003196A patent/MXPA06003196A/es unknown
- 2004-09-24 EP EP04768659A patent/EP1668016A1/en not_active Withdrawn
- 2004-09-24 US US10/573,133 patent/US7982038B2/en not_active Expired - Fee Related
- 2004-09-24 AU AU2004276061A patent/AU2004276061A1/en not_active Abandoned
- 2004-09-24 CA CA002538705A patent/CA2538705A1/en not_active Abandoned
- 2004-09-24 WO PCT/GB2004/004116 patent/WO2005030778A1/en active Application Filing
-
2006
- 2006-03-09 IL IL174218A patent/IL174218A0/en unknown
- 2006-03-24 ZA ZA200602445A patent/ZA200602445B/en unknown
- 2006-04-25 NO NO20061819A patent/NO20061819L/no not_active Application Discontinuation
-
2009
- 2009-02-27 AU AU2009200802A patent/AU2009200802A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2009200802A1 (en) | 2009-03-19 |
NZ546414A (en) | 2009-07-31 |
BRPI0414633A (pt) | 2006-11-07 |
AU2004276061A1 (en) | 2005-04-07 |
IL174218A0 (en) | 2006-08-01 |
US7982038B2 (en) | 2011-07-19 |
EP1668016A1 (en) | 2006-06-14 |
KR20060102328A (ko) | 2006-09-27 |
US20070172420A1 (en) | 2007-07-26 |
ZA200602445B (en) | 2007-09-26 |
JP4792393B2 (ja) | 2011-10-12 |
CA2538705A1 (en) | 2005-04-07 |
MXPA06003196A (es) | 2006-06-23 |
WO2005030778A1 (en) | 2005-04-07 |
CN1856497A (zh) | 2006-11-01 |
JP2007506719A (ja) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054852L (no) | GFAT inhibitorer | |
MX2009004910A (es) | Compuestos sustituidos de 3-isobutil-9,10-dimetoxi-1,3,4,6,7,11-b- hexahidro-2h-pirido[2,1-a] isoquinolin-2-ol y métodos que se relacionan al mismo. | |
NO20082389L (no) | 2,3,4-trifenylimidazolinderivater som inhibitor av interaksjonen mellom P53- og MDM2-proteiner for anvendelse som antikreftmidler | |
WO2008120725A1 (ja) | 新規ピロリノン誘導体およびそれを含有する医薬組成物 | |
NO20091409L (no) | Pyridin-3-yl-derivater som immunmodulerende midler | |
NO20084129L (no) | Pyridin(3,4-B)Pyrazinoner | |
SE0202430D0 (sv) | New Compounds | |
NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
TW200619199A (en) | 3-carbamoyl-2-pyridone derivatives | |
MY137944A (en) | Specific glucocorticoid compounds having anti-inflammatory activity | |
TW200502230A (en) | Dual nk1/nk3 derivatives | |
NO20082561L (no) | Nye koblede pyrrolderivater | |
NO20084915L (no) | Nikotinacetylcholinreseptorligander 101 | |
HK1155146A1 (zh) | 作為藥物活性劑的茚衍生物 | |
GEP20104964B (en) | 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
NO20045486L (no) | Nye forbindelser og deres anvendelse | |
NO20073551L (no) | Nikotinacetylkolinreseptorligander | |
NO20052182L (no) | Nye forbindelser | |
NO20062629L (no) | Oksazolderivater av tetrackliner | |
NO20072753L (no) | 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer | |
UA96947C2 (ru) | Производные циннамоил-пиперазина и их применение как антагонистов par-1 | |
TW200728298A (en) | Thiophene compounds and thrombopoietin receptor activators | |
NO20080033L (no) | Kinolinderivater som NK3-antagonister | |
NO20080110L (no) | Benzimidazolderivativer som 5-HT6,5-HT24 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |